Published by pharmaphorum.com
Are you prepared for the upcoming changeover to the new EU risk management plan (RMP) template? Seema Jaitly offers some timely guidance on the new EU RMP document.
About the author:
Dr Seema Jaitly qualified in Medicine from Charing Cross and Westminster Medical School in 1992 and worked in hospital medicine for four years. She has worked in the pharma industry for over 18 years at CROs and companies spanning clinical research, medical affairs, pharmacovigilance and the EU QPPV role.
In 2010 she founded Essjay Solutions to offer pharmacovigilance services, consultancy and contracting services.
She is currently in the final year of her MSc in epidemiology with the London School of Hygiene and Tropical Medicine.